Literature DB >> 9489655

Pneumococcal pericarditis with cardiac tamponade in a patient with chronic graft-versus-host disease.

J A Pérez Retortillo1, F Marco, C Richard, E Conde, R Manjón, E Bureo, A Iriondo, A Zubizarreta.   

Abstract

We report a case of pneumococcal pericarditis in a 13-year-old boy following allogeneic BMT from an HLA-identical unrelated donor. The post-transplant course was complicated by chronic GVHD which led to reinstitution of immunosuppressive therapy. Eight months after BMT the patient developed pericarditis with cardiac tamponade, and Streptococcus pneumoniae was isolated in the pericardiocentesis fluid. This is the first reported case of pneumococcal pericarditis after BMT. Although pericardial effusions after allogeneic BMT are often sterile and related to conditioning therapy or associated with chronic GVHD, rapid microbiological investigation and empirical treatment with antibiotics are necessary. Prophylaxis for pneumococcal infection in patients with chronic GVHD is recommended.

Entities:  

Mesh:

Year:  1998        PMID: 9489655     DOI: 10.1038/sj.bmt.1701072

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  3 in total

1.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

2.  Large pericardial effusion as a complication in adults undergoing SCT.

Authors:  M Norkin; V Ratanatharathorn; L Ayash; M H Abidi; Z Al-Kadhimi; L G Lum; J P Uberti
Journal:  Bone Marrow Transplant       Date:  2010-11-29       Impact factor: 5.483

Review 3.  Pneumococcal arthritis affects performance status in patients with chronic GVHD of the skin following allogeneic bone marrow transplantation.

Authors:  N Sakata; M Yasui; K Kawa
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.